baber/WOPTO huggingface dataset:
Patent AU-2019210203-A1 (AU)
Title: System information monitoring
Inventor: JOHN WILSON MAKESH PRAVIN
IPC: H04W48/12
Filed: 2019-01-18
Abstract: Various aspects of the present disclosure generally relate to wireless communication. In some aspects, a user equipment (UE) may determine a remaining minimum system information control resource set (RMSI CORESET) monitoring configuration based at least in part on information received by the UE in a first frame; and monitor, during a second frame and based at least in part on the RMSI CORESET monitoring configuration, for an RMSI CORESET based at least in part on a synchronization signal block (SSB), associated with the RMSI CORESET, that is received in the first frame. Numerous other aspects are provided.
Patent AU-2019210970-A1 (AU)
Title: Solids-packed apparatus for performance of endothermic reactions with direct electrical heating
Inventor: APPEL HAGEN
IPC: F27D11/04
Filed: 2019-01-22
Abstract: The present invention relates to an electrically heatable packed pressure-bearing device for performing endothermic reactions having an upper (3), middle (1) and lower (3) device section, wherein at least one vertically disposed electrode pair (4, 5) is fitted in the middle section (1) and all electrodes are arranged in an electrically conducting solid packing (26), the upper and lower device sections have a specific conductivity of 10
Patent AU-2019214338-A1 (AU)
Title: Soft tissue balancing in robotic knee surgery
Inventor: COUTURE PIERRE
IPC: A61B34/30
Filed: 2019-02-01
Abstract: A system and method may be used to evaluate soft tissue. A knee arthroplasty soft tissue evaluation may use an adjustable spacer, such as varying sized physical spacers or an inflatable bladder, along with a sensor to measure force, pressure, gap distance, or the like during a range of motion test. A method may include maintaining an equal pressure or gap distance for a medial component and a lateral component of an adjustable spacer during a range of motion test. Information, including, for example a maximum or minimum gap distance or pressure may be determined during the range of motion test. The determined information may be output for display or used to update a surgical plan.
Patent AU-2019222865-A1 (AU)
Title: Electronic vaporization devices
Inventor: WENSLEY MARTIN
IPC: A24F40/485
Filed: 2019-08-28
Abstract: A device for generating an aerosol, comprising: a liquid reservoir for holding a liquid; a tube including one or more tube outlets; 5 a heater around the tube; and a pump positioned to pump liquid from the reservoir through the tube, out through the tube outlets, and onto the heater. 11655657_1(GHMatters)P106373.AU.1 cx LC) t 8 cc W-~-~kt C (N ~cc t 'N k\ < fit (0 K tN~ ½ pA p p 2½ 1 '\ ½
Patent AU-2019229076-A1 (AU)
Title: Anti-TIGIT antibodies and uses thereof
Inventor: LEE KWANG-HOON
IPC: A61K47/68
Filed: 2019-02-28
Abstract: Disclosed are a novel antibody specifically binding to the tumor-immunosuppressant, TIGIT (T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif [ITIM] domain) or an antigen-binding fragment thereof, a nucleic acid encoding the antibody or the antigen-binding fragment thereof, a vector and a host cell including the nucleic acid, a method for producing the antibody or the antigen-binding fragment thereof, a pharmaceutical composition containing the antibody or the antigen-binding fragment thereof as an active ingredient, and uses of the pharmaceutical composition. The antibody specifically binding to TIGIT or the antigen-binding fragment thereof and the pharmaceutical composition containing the same as an active ingredient are preferably used for the treatment of cancer or tumors.
Patent AU-2019240593-A1 (AU)
Title: Antibodies directed against programmed death-1 (PD-1)
Inventor: KING DAVID J
IPC: C07K16/28
Filed: 2019-10-01
Abstract: Abstract: The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that bind to a programmed death-i (PD-1) protein. The invention provides a PD-1-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. The invention also provides related vectors, compositions, and methods of using the PD-I-binding agent to treat a cancer or an infectious disease.
Patent AU-2019254726-A1 (AU)
Title: Microneedle system for applying interferon
Inventor: HENKE STEFAN
IPC: A61K38/21
Filed: 2019-04-23
Abstract: The invention relates to a microneedle system (MNS) for the intradermal application of interferon, in which polyvinylpyrrolidone is the main component of a completely soluble formulation.
Patent AU-2019266795-A1 (AU)
Title: Long-acting injectable formulations and crystalline forms of buprenorphine derivatives
Inventor: LIN TONG-HO
IPC: C07D489/12
Filed: 2019-05-10
Abstract: This disclosure relates to crystalline forms of 3-acyl-buprenorphine derivatives and sustained release injectable pharmaceutical compositions for treatment of opioid dependence, pain or depression, including an aqueous suspension of crystalline 3-acyl-buprenoprhine, or a pharmaceutically acceptable salt thereof, wherein the composition does not include an organic solvent, a polylactide polymer, a polyglycolide polymer, or a copolymer of polylactide and polyglycolide. This disclosure also includes 3-acyl-buprenoprhine or a pharmaceutically acceptable salt thereof prepared in a controlled release matrix, including poly (lactide-co-glycolide), sucrose acetoisobutyrate, lecithin, diolein and a combination of two or more thereof.
Patent AU-2019269348-A1 (AU)
Title: Blood flow restricting headwear
Inventor: VENTURI MARK LOUIS
IPC: A61B17/135
Filed: 2019-05-10
Abstract: A blood flow restricting apparatus (100) is provided. The blood flow restricting apparatus (100) can include a frame element (70) configured to be securable to a user's head. At least one cooling pad (60) can be operatively arranged with the adjustable frame element (70) and configured to be arranged over a defined anatomic location including at least one of a pair of supratrochlear arteries (20), a pair of supraorbital arteries (30), a pair of temporal arteries (40), and a pair of occipital arteries (50) of the user's head. The at least one cooling pad (60) can include a cooling element (62) capable of producing a cooling effect. A pressurizing mechanism (90) can be operatively arranged with the at least one cooling pad (60) and capable of pressing the at least one cooling pad (60) against the defined anatomic location to restrict blood flow to each of the targeted arteries while simultaneously cooling the defined anatomic location.
Patent AU-2019282698-A1 (AU)
Title: In-line measurement of fill system
Inventor: BERNACKI JOSEPH
IPC: G01F11/12
Filed: 2019-06-06
Abstract: The field of the invention relates generally to filling containers with liquid. More specifically, the invention relates to the real-time assessment of the volume filled into containers, particularly in the manufacture of medicaments such as pharmaceuticals. The invention finds specific use in the final stage of drug manufacturing known as fill/finish wherein the drug substance or active pharmaceutical intermediate is prepared as a final drug product in a formulation suitable for administration to patients in need of the same, which is then provided to patients. More particularly, the invention relates to controlling the volume in container via in-line non-destructive monitoring of the fill process.
Patent AU-2019294690-A1 (AU)
Title: CRISPR/Cas and transposase based amplification compositions, systems and methods
Inventor: ZHANG FENG
IPC: C12Q1/68
Filed: 2019-06-26
Abstract: Provided herein are methods and systems for detecting a target nucleic acid sequence. The method comprises contacting an oligonucleotide comprising the target nucleic acid sequence with a transposon complex; inserting one or more T7 RNA promoters into the oligonucleotide using the transposase; and (c) amplifying the target nucleic acid sequence. The transposon complex may comprise a transposase and a transposon sequence comprising one or more T7 RNA promoters. The target nucleic sequence may be amplified by generating RNA oligonucleotides comprising the target nucleic acid sequence via transcription from the inserted one or more T7 RNA promoters. The amplified target nucleic acid may be detected using a CRISPR Cas13-based detection system.
Patent AU-2019307774-A1 (AU)
Title: Purification of recycled and renewable organic material
Inventor: TOUKONIITTY BLANKA
IPC: C11B3/06
Filed: 2019-07-19
Abstract: Provided herein is a method of purifying a recycled or renewable organic material, wherein the recycled or renewable organic material comprises one or more impurities selected from a group consisting of silicon compounds, phosphorous, Cl and sterols, comprising the steps of (a) providing the recycled or renewable organic material; (b) optionally pre heat treating the recycled or renewable organic material at 180 to 325°C, and optionally adding acid before or after the pre heat treatment process, and optionally filtering the pre heat treated recycled or renewable organic material after the pre heat treatment; (c) heat treating the recycled or renewable organic material at 100 to 450°C, optionally in the presence of an adsorbent, optionally adding water before or during the heat treatment process, and optionally adding acid before or after the heat treatment process, and optionally filtering the heat treated recycled or renewable organic material after the heat treatment; (d) optionally evaporating volatile silicon compounds from the heat treated recycled or renewable organic material compounds thereby reducing the silicon content of the heat treated recycled or renewable organic material; (e) optionally thermally cracking the recycled or renewable organic material thereby reducing the oxygen and phosphorous content of the heat treated recycled or renewable organic material, and optionally removing volatiles from the thermally cracked recycled or renewable organic material, and optionally removing solids/precipitates from the recycled or renewable organic material; and (f) hydrotreating the heat treated recycled or renewable organic material in a presence of a hydrotreating catalyst; to obtain purified hydrotreated recycled or renewable organic material.
Patent AU-2019338073-A1 (AU)
Title: Device and method for detecting railway equipment defects
Inventor: PERTOSA VITO
IPC: B61L25/02
Filed: 2019-09-02
Abstract: Device for detecting railway equipment defects, comprising at least three diagnostic modules mounted on a generic railway vehicle: a first module (geometrical module) configured to measure at least a geometrical feature of the track; a second module (acceleration module) configured to measure in at least a point of said vehicle the side and/or vertical accelerations transmitted from the track to said vehicle; a third module (visual module) configured to acquire the images of the track elements and to analyze them to verify the presence of anomalies; said modules being configured to associate with each detection carried out when the railway vehicle passes, on which they are mounted, the position where the detection was carried out and to calculate, for each detection, a severity index representative of the deviation of the detection with respect to the standard condition without defects.
Patent AU-2019351762-A1 (AU)
Title: Integrated inkjet module for scalable printer
Inventor: PROFACA MARK
IPC: B41J29/02
Filed: 2019-09-16
Abstract: An integrated inkjet module includes: a support chassis configured for fixedly mounting on a media feed chassis; a maintenance chassis slidably mounted on the support chassis; and a print bar chassis liftably mounted on the maintenance chassis, the print bar chassis having one or more inkjet printheads mounted thereon.
Patent AU-2019354714-A1 (AU)
Title: Humanised anti-N-truncated amyloid beta monoclonal antibody
Inventor: BAYER THOMAS
IPC: C07K16/18
Filed: 2019-10-02
Abstract: The present invention relates to humanised antibodies that bind amyloid peptides, which antibodies comprise mutations in the heavy chain and/or light chain variable domains, which mutations improve the binding activity. The antibodies may be useful in the treatment of Alzheimer's disease (AD).
Patent AU-2019362458-A1 (AU)
Title: Treatment of neuropathy with IGF-1-encoding DNA constructs and HGF-encoding DNA constructs
Inventor: LEE JUNGHUN
IPC: A61K38/00
Filed: 2019-07-16
Abstract: The present invention relates to a method of treating neuropathy by administering DNA constructs, encoding a human IGF-l isoform and a human HGF isoform. Further provided herein are various DNA constructs and pharmaceutical compositions including the DNA constructs that can be used for the combination therapy. The present invention provides a safe and effective way of treating neuropathic patients.
Patent WO-2020237305-A1 (WO)
Inventor: PETER KARLHEINZ
IPC: A61K38/46
Filed: 2020-05-27
Abstract: The present invention provides a method of treating or preventing an inflammatory neurological disease in a subject, the method comprising administering to the subject a protein comprising an extracellular domain of CD39. The present invention also relates to binding proteins comprising an extracellular domain of CD39.
Patent AU-2020203743-A1 (AU)
Title: Lipid comprising docosapentaenoic acid
Inventor: PETRIE JAMES ROBERTSON
IPC: C11B1/10
Filed: 2020-06-05
Abstract: The present invention relates to extracted plant lipid or microbial lipid comprising docosapentaenoic acid, and processes for producing the extracted lipid.
Patent AU-2020204057-A1 (AU)
Title: Advanced database decompression
Inventor: LASCH ROBERT
IPC: H03M7/00
Filed: 2020-06-18
Abstract: A method, a system, and a computer program product for decompressing data. One or 
more compressed blocks in a set of stored compressed blocks responsive to a request to access 
data in the set of stored compressed blocks are identified. String prefixes inside the identified 
compressed blocks are decompressed using front coding. String suffixes inside the identified 
compressed blocks are decompressed using a re-pair decompression. Uncompressed data is 
generated.  
12445111_1 (GHMatters) P113820.AU
Patent AU-2020204137-A1 (AU)
Title: An embolisation device
Inventor: MULLINS LIAM
IPC: A61B17/12
Filed: 2020-06-22
Abstract: An embolisation device for promoting clot formation in a lumen. The embolization device has a 
proximal segment and a distal segment. Each segment has a stem and a plurality of flexible 
bristles extending outwardly from the stem. The bristles have a contracted delivery 
configuration and a deployed configuration in which the bristles extend generally radially 
outwardly from the stem to anchor the device in a lumen. In the deployed configuration bristles 
of the proximal segment extend partially in a first longitudinal direction and the bristles of the 
distal segment extend partially in a second longitudinal direction which is opposite to the first 
longitudinal direction. The embolization device has a connector between adjacent segments. An 
inflexible proximal connection is provided between the proximal segment and the segment 
adjacent to the proximal segment.
Patent AU-2020229919-A1 (AU)
Title: Process for preparing 6- (1-Acryloylpiperidin-4-yl) -2- (4-phenoxyphenyl) nicotinamide
Inventor: CHEN XIANGYANG
IPC: A61P35/00
Filed: 2020-02-24
Abstract: Disclosed the processes for preparing 6- (1-Acryloylpiperidin-4-yl) -2-(4-phenoxyphenyl) nicotinamide (Compound I) in a large scale of over 1 Kg. The processes provide a good yield and a purity of at least 95% of the final product and provide a controllable and safe reaction.
Patent AU-2020231093-A1 (AU)
Title: Nasal mask and securement system
Inventor: MICHELSEN LARISSA GRACE
IPC: A61M16/06
Filed: 2020-02-28
Abstract: A patient interface for respiratory therapy includes a mask seal body defining a breathing chamber and having a user-contacting surface configured to contact a face of the user and surround at least the nares of the user. The patient interface also includes a pair of facial pads, each of the facial pads configured to engage the face of a user on opposing sides of the mask seal body. The facial pads are coupled to the mask seal body. The patient interface comprises a sealing mechanism configured to urge the mask seal body toward the user's face to create or maintain sealing engagement between the user-contacting surface and the user's face. In some configurations, the sealing mechanism includes a curved bridging portion that extends between the mask seal body and each of the facial pads.
Patent AU-2020268370-A1 (AU)
Title: Methods of producing continuously cast hot rolled high strength steel sheet products
Inventor: HOYDICK DAVID PAUL
IPC: C22C38/04
Filed: 2020-05-06
Abstract: Methods of producing high strength continuously cast hot rolled steel sheet products are disclosed. The methods include continuously casting a steel slab and then hot rolling with finish rolling on a hot strip mill, quenching on the hot strip mill to form a predominantly matrensitic microstructure, and performing a thermal cycling step including soaking at an intercritical temperature followed by holding at a lower temperature. The resultant hot rolled steel sheet products have a microstructure comprising ferrite and retained austenite. Steels processed in accordance with the present invention exhibit favorable combined ultimate tensile strength and total elongation (UTS•TE) properties, and may fall into the category of Generation 3 advanced high strength steels, desirable in various industries including automobile manufacturers.
Patent AU-2020282750-A1 (AU)
Title: Valve assembly for drug delivery device
Inventor: FALKOVICH MARGARITA
IPC: A61M5/24
Filed: 2020-05-29
Abstract: A valve assembly for a drug delivery device includes a valve housing having a first side and a second side positioned opposite from the first side, a cannula having a first end and a second end positioned opposite the first end, a pierce plate having a body and a piercing member extending from the body, with the body defining a coiled elongate member, and a valve boot connected to the valve housing and defining an interior space. The valve boot is configured to move from a pre-use position where the first end of the cannula and the piercing member of the pierce plate are received within the interior space to a use position where the piercing member of the pierce plate and the first end of the cannula extend outside of the valve boot and the interior space.
Patent AU-2020317870-A1 (AU)
Title: Device and method for vision rehabilitation
Inventor: LUCIA UMBERTO
IPC: G16H20/30
Filed: 2020-07-08
Abstract: The invention consists of an apparatus and a method for vision rehabilitation, wherein said apparatus comprises communication means (13), visualization means (11) and processing means (16) configured to receive, through the communication means (13), a plurality of data that define a visual field of at least one eye of a patient, generate a therapeutic image on the basis of said plurality of data, and visualized, through said visualization means (11), said therapeutic image, wherein said therapeutic image has geometric and/or chromatic features which, if perceived by the patient, stimulate a regeneration of tissues comprised in the visual apparatus of said patient.
Patent AU-2020326438-A1 (AU)
Title: Control of an engine of a machine based on detected load requirements of the machine
Inventor: KURAS BRIAN
IPC: F02D29/06
Filed: 2020-07-14
Abstract: An electronic control unit to control an engine control module of an engine is disclosed. The electronic control unit may receive, from a load monitoring device, power command information associated with a load of an engine. The electronic control unit may determine, based on the power command information, a total power command of the engine. The electronic control unit may determine, based on the total power command, a target engine speed for the engine. The electronic control unit may cause an engine control module to control the engine to operate in association with the target engine speed.
Patent AU-2020334967-A1 (AU)
Title: Compositions and particles for payload delivery
Inventor: MRSNY RANDALL J
IPC: A61K9/64
Filed: 2020-08-14
Abstract: The present disclosure provides complexes and compositions comprising particles, microparticles or nanoparticles, for delivery of payloads into a cell or across a polarized epithelial cell. The compositions can comprise a payload in a pill or tablet for delivery of the payload into or across a polarized epithelial cell.
Patent AU-2020351063-A1 (AU)
Title: Cracking long chained hydrocarbons from plastic-containing waste and organic liquids
Inventor: VAN DER REE TEUNIS CHRISTIAAN
IPC: C10G9/00
Filed: 2020-09-18
Abstract: The invention provides a method for breaking down long chained hydrocarbons from plastic-containing waste and organic liquids based on crude oil, comprising providing material containing long-chained hydrocarbons; heating a specific volume of the material containing long-chained hydrocarbons to a cracking temperature, at which cracking temperature the chains of hydrocarbons in the material start cracking into shorter chains; and for the specific volume having a temperature above the cracking temperature, exposing the specific volume to heat which is less than or equal to 50 °C above the temperature of the specific volume. The invention also provides an apparatus for carrying out the invention.
Patent AU-2020351883-A1 (AU)
Title: System and method for signal re-transmission
Inventor: ALUSH HENRY VICTOR
IPC: G01S7/02
Filed: 2020-09-24
Abstract: System and for signal re-transmission including a channelizer, a signal-effect-processor and a controller. The signal-effect-processor includes a plurality of sub-band-processors and a summer. The channelizer receives a sampled Intermediate-Frequency signal exhibiting a first sampling-rate. The channelizer produces a plurality of sub-band-signals, each associated with a respective sub-band of the Intermediate-Frequency signal. Each sub-band-signal exhibit a second sampling-rate lower than the first sampling-rate. Each of at least one selected sub-band-processor receives a respective sub-band-signal, introduces at least one effect to the respective sub-band-signal, and increases the sampling-rate of the respective sub-band-signal to the first sampling-rate, thereby producing a respective affected sub-band re-transmit signal. Each selected sub-band-processor is further provides the respective affected sub-band re-transmit signal to a respective input of the summer. The summer sums the inputs thereof to produce a wideband affected re-transmit signal. The controller selects the selected sub-band processor and controls settings of the at least one effect.
Patent AU-2020370740-A1 (AU)
Title: Methods for generating, and sequencing from, asymmetric adaptors on the ends of polynucleotide templates comprising hairpin loops
Inventor: GORMLEY NIALL ANTHONY
IPC: C12Q1/6806
Filed: 2020-10-23
Abstract: A method of generating an asymmetric closed-ended double stranded nucleic acid template from a double stranded nucleic acid template having free 5' and 3' ends by use of hairpin or dumbbell adaptors, and sequencing therefrom.